163 related articles for article (PubMed ID: 12586750)
1. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis.
Choi K; Roh SG; Hong YH; Shrestha YB; Hishikawa D; Chen C; Kojima M; Kangawa K; Sasaki S
Endocrinology; 2003 Mar; 144(3):754-9. PubMed ID: 12586750
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
Cunha SR; Mayo KE
Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
Kineman RD; Kamegai J; Frohman LA
Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2.
Dieudonne MN; Pecquery R; Leneveu MC; Giudicelli Y
Endocrinology; 2000 Feb; 141(2):649-56. PubMed ID: 10650946
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin directly regulates bone formation.
Fukushima N; Hanada R; Teranishi H; Fukue Y; Tachibana T; Ishikawa H; Takeda S; Takeuchi Y; Fukumoto S; Kangawa K; Nagata K; Kojima M
J Bone Miner Res; 2005 May; 20(5):790-8. PubMed ID: 15824852
[TBL] [Abstract][Full Text] [Related]
7. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.
Korbonits M; Bustin SA; Kojima M; Jordan S; Adams EF; Lowe DG; Kangawa K; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):881-7. PubMed ID: 11158061
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity.
Shuto Y; Shibasaki T; Otagiri A; Kuriyama H; Ohata H; Tamura H; Kamegai J; Sugihara H; Oikawa S; Wakabayashi I
J Clin Invest; 2002 Jun; 109(11):1429-36. PubMed ID: 12045256
[TBL] [Abstract][Full Text] [Related]
9. Developmental, stage-specific, and hormonally regulated expression of growth hormone secretagogue receptor messenger RNA in rat testis.
Barreiro ML; Suominen JS; Gaytán F; Pinilla L; Chopin LK; Casanueva FF; Diéguez C; Aguilar E; Toppari J; Tena-Sempere M
Biol Reprod; 2003 May; 68(5):1631-40. PubMed ID: 12606422
[TBL] [Abstract][Full Text] [Related]
10. Structure and regulation of the growth hormone secretagogue receptor.
Petersenn S
Minerva Endocrinol; 2002 Dec; 27(4):243-56. PubMed ID: 12511847
[TBL] [Abstract][Full Text] [Related]
11. Homologous and heterologous regulation of pituitary receptors for ghrelin and growth hormone-releasing hormone.
Luque RM; Kineman RD; Park S; Peng XD; Gracia-Navarro F; Castaño JP; Malagon MM
Endocrinology; 2004 Jul; 145(7):3182-9. PubMed ID: 15044357
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-releasing hormone (GHRH) neurons in the arcuate nucleus (Arc) of the hypothalamus are decreased in transgenic rats whose expression of ghrelin receptor is attenuated: Evidence that ghrelin receptor is involved in the up-regulation of GHRH expression in the arc.
Mano-Otagiri A; Nemoto T; Sekino A; Yamauchi N; Shuto Y; Sugihara H; Oikawa S; Shibasaki T
Endocrinology; 2006 Sep; 147(9):4093-103. PubMed ID: 16728494
[TBL] [Abstract][Full Text] [Related]
13. Expression and homologous regulation of GH secretagogue receptor mRNA in rat adrenal gland.
Barreiro ML; Pinilla L; Aguilar E; Tena-Sempere M
Eur J Endocrinol; 2002 Nov; 147(5):677-88. PubMed ID: 12444901
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin regulates proliferation and differentiation of osteoblastic cells.
Maccarinelli G; Sibilia V; Torsello A; Raimondo F; Pitto M; Giustina A; Netti C; Cocchi D
J Endocrinol; 2005 Jan; 184(1):249-56. PubMed ID: 15642801
[TBL] [Abstract][Full Text] [Related]
15. Roles of leptin and ghrelin in adipogenesis and lipid metabolism of rainbow trout adipocytes in vitro.
Salmerón C; Johansson M; Asaad M; Angotzi AR; Rønnestad I; Stefansson SO; Jönsson E; Björnsson BT; Gutiérrez J; Navarro I; Capilla E
Comp Biochem Physiol A Mol Integr Physiol; 2015 Oct; 188():40-8. PubMed ID: 26103556
[TBL] [Abstract][Full Text] [Related]
16. High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary.
Nass R; Gilrain J; Anderson S; Gaylinn B; Dalkin A; Day R; Peruggia M; Thorner MO
Endocrinology; 2000 Jun; 141(6):2084-9. PubMed ID: 10830294
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone secretagogues and ghrelin: an update on physiology and clinical relevance.
Petersenn S
Horm Res; 2002; 58 Suppl 3():56-61. PubMed ID: 12435899
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor.
Thompson NM; Gill DA; Davies R; Loveridge N; Houston PA; Robinson IC; Wells T
Endocrinology; 2004 Jan; 145(1):234-42. PubMed ID: 14551228
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism.
Zalatan F; Krause JA; Blask DE
Endocrinology; 2001 Sep; 142(9):3783-90. PubMed ID: 11517154
[TBL] [Abstract][Full Text] [Related]
20. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes.
Kim MS; Yoon CY; Jang PG; Park YJ; Shin CS; Park HS; Ryu JW; Pak YK; Park JY; Lee KU; Kim SY; Lee HK; Kim YB; Park KS
Mol Endocrinol; 2004 Sep; 18(9):2291-301. PubMed ID: 15178745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
